loader from loading.io

Martha Kaiser: From Melanoma Diagnosis to Genetic Discovery – A Journey of Agency and Ancestry

Walking the Genetic Line

Release Date: 11/13/2025

Beth Martinetti: Family, Fertility, and Identity after Hereditary Cancer Diagnosis show art Beth Martinetti: Family, Fertility, and Identity after Hereditary Cancer Diagnosis

Walking the Genetic Line

Episode Summary When Beth Martinetti—Pilates instructor, mother of three, and lifelong student of her own body—discovered multiple genetic mutations at 45, it was the latest chapter in a lifetime shaped by both visible and invisible challenges. Beth shares her journey from adolescent injury and Ehlers-Danlos diagnosis, through complicated pregnancies, to a midlife cascade: mysterious symptoms, pivotal encounters with validating doctors, and ultimately, the discovery that she carries BRCA1, CHEK2, and a variant in BARD1. Still in the thick of surgical recovery, Beth invites us into her...

info_outline
Dr. Corinne Menn: The Truth About Hormone Replacement for BRCA Carriers and Previvers show art Dr. Corinne Menn: The Truth About Hormone Replacement for BRCA Carriers and Previvers

Walking the Genetic Line

Guest: Dr. Corinne Menn Theme: Claiming agency in hereditary cancer risk, surgical menopause, and a new era of HRT care Episode summary When Dr. Corinne Menn—board certified OB/GYN, Menopause Society certified practitioner, 23+ year breast cancer survivor, and BRCA2 carrier—joins us, she brings unparalleled lived and clinical expertise to walking the genetic line. In this conversation, Dr. Corinne Menn shares her deeply personal journey: breast cancer at 28, the loss of her mother to ovarian cancer, and the years navigating her own genetic risk and premature menopause. Together, we...

info_outline
Martha Kaiser: From Melanoma Diagnosis to Genetic Discovery – A Journey of Agency and Ancestry show art Martha Kaiser: From Melanoma Diagnosis to Genetic Discovery – A Journey of Agency and Ancestry

Walking the Genetic Line

Guest: Martha Kaiser Theme: Walking with CDKN2A, Ancestral Discovery, and Agency in Rare Genetic Mutations Episode Summary When Martha Kaiser discovered she carries the rare CDKN2A gene mutation—known for elevating risks of melanoma and pancreatic cancer—her journey shifted from uncertainty, loss, and family trauma to active agency and deep exploration. In this conversation, she shares not only the medical dimensions of living with a lesser-known mutation, but how intergenerational silence, gut intuition, and the drive to protect her children led her to become both a patient advocate and a...

info_outline
Solo Episode: What “Evidence-Based Care” Really Means: Bridging Science, Trauma, and Healing Hereditary Cancer show art Solo Episode: What “Evidence-Based Care” Really Means: Bridging Science, Trauma, and Healing Hereditary Cancer

Walking the Genetic Line

🧬 Episode Summary In this solo episode, host Sara Champie, LCSW, explores one of the most common phrases in medicine and psychology—evidence-based care—and what it really means when we apply it to lived human experience. Sara walks us through the two definitions that often get conflated: evidence-based research, which measures outcomes in controlled studies, and evidence-based practice, which integrates science, clinical wisdom, and a client’s unique values and culture. She then bridges these frameworks through the lens of hereditary cancer risk, showing how the most profound healing...

info_outline
Katherine Lewandowski: Reclaiming Self After Preventative Surgery show art Katherine Lewandowski: Reclaiming Self After Preventative Surgery

Walking the Genetic Line

Guest: Katherine Lewandowski Theme: Choosing care, surviving change, and finding a stronger self after prophylactic surgery Episode summary When Katherine learned at 43 that she carried BRCA2—shortly after her father’s metastatic prostate cancer diagnosis—she moved from shock and shame to decisive action. In this conversation, she shares how grief, meticulous research, and a values-aligned care team led her through prophylactic bilateral mastectomy with DIEP flap reconstruction and surgical menopause—and why she now feels more like herself: stronger, clearer, and more alive. We...

info_outline
Lisa Sharpstone: Choosing on Her Own Terms show art Lisa Sharpstone: Choosing on Her Own Terms

Walking the Genetic Line

Episode Summary In this deeply moving conversation, we meet Lisa, a 50-year-old woman from the UK navigating her BRCA2 genetic mutation. After undergoing an oophorectomy and preparing for a double mastectomy, Lisa shares candidly about her journey through testing, family reactions, and the intimate decisions around reconstruction, femininity, and sexuality. Together, we explore how genetic testing within the Jewish community intersects with intergenerational trauma, cultural history, and personal agency. Lisa’s story highlights the ripple effects of genetic information across families, the...

info_outline
Solo Episode: Internal Security Vs. External Safety show art Solo Episode: Internal Security Vs. External Safety

Walking the Genetic Line

Episode Summary: In this solo episode of Walking the Genetic Line, therapist and host Sara Champie invites listeners to explore a subtle but powerful distinction: the difference between external safety and internal security. Through a trauma-informed lens, Sara reflects on how our nervous systems constantly scan for safety—and how our earliest relationships shape the way we respond to uncertainty and risk throughout life. Drawing from Polyvagal Theory, interpersonal neurobiology, and her own clinical practice, Sara offers an honest look at what it means to live in an unpredictable...

info_outline
Dr. LaDeana Jeane: Integrative Oncology and the Personal Side of Hereditary Cancer Risk show art Dr. LaDeana Jeane: Integrative Oncology and the Personal Side of Hereditary Cancer Risk

Walking the Genetic Line

Episode Summary In this powerful conversation, Dr. LaDeana Jeane—naturopathic doctor and integrative oncology specialist—shares her expertise and personal story. LaDeana blends medical training with lived experience, offering a unique perspective on how hereditary cancer risk intersects with hormonal health, prophylactic surgeries, and long-term survivorship. She opens up about undergoing a bilateral mastectomy at just 19 years old following her mother’s breast cancer diagnosis, the decades-long journey of recovery and reconstruction, and the courage it has taken to bring her story into...

info_outline
Bonus Episode: Fear and HRT show art Bonus Episode: Fear and HRT

Walking the Genetic Line

Episode Summary: In this solo episode, I explore one of the most debated areas of care for BRCA mutation carriers: hormone replacement therapy (HRT). While evidence—including the 2016 North American Menopause Society (NAMS) Practice Pearl—supports the use of systemic HRT for many BRCA carriers after risk-reducing surgery, fear and cultural stigma around hormones continue to shape medical recommendations. I discuss why some doctors may still discourage HRT for BRCA2 carriers, not because of strong scientific evidence, but because of lingering emotional and cultural fears around breast...

info_outline
Danielle Service: The Patriarchy Wants My T*ts show art Danielle Service: The Patriarchy Wants My T*ts

Walking the Genetic Line

This podcast, Walking the Genetic Line, was made to create a container in which there are no right or wrongs about how to relate with genetic testing results. This space was made to explore how we are impacted hereditary cancer, what influences our experience, what we wrestle with— and FEEL—about this information. Danielle Service brought her raw, unfiltered truth to this interview: how genetic testing felt like an unnecessary burden for the first chapter, how that changed over time, and the questions and concerns she still has about the social and cultural context of the risk management...

info_outline
 
More Episodes

Guest: Martha Kaiser
Theme: Walking with CDKN2A, Ancestral Discovery, and Agency in Rare Genetic Mutations

Episode Summary
When Martha Kaiser discovered she carries the rare CDKN2A gene mutation—known for elevating risks of melanoma and pancreatic cancer—her journey shifted from uncertainty, loss, and family trauma to active agency and deep exploration. In this conversation, she shares not only the medical dimensions of living with a lesser-known mutation, but how intergenerational silence, gut intuition, and the drive to protect her children led her to become both a patient advocate and a creative genealogist, tracing the roots and ripple effects of her family’s cancer history. Her story explores how knowledge, connection, and community can bring both practical peace and a kind of healing across generations.

We Cover

  • The emotional backdrop: losing her mother young to multiple cancers, and carrying a sense of unspoken family trauma

  • How shifting cancer narratives across generations inspired Martha’s vow for transparency and openness with her own children

  • The surprise and shock of receiving a positive CDKN2A result after full-panel genetic testing (having initially been tested for BRCA)

  • Navigating surveillance for pancreatic, brain, and breast cancers with annual MRIs, endoscopies, and proactive self-advocacy

  • Turning to genealogy—and partnering with Connect My Variant and BYU researchers—to untangle the ancestral origins of her “typo” and connect with long-lost relatives

  • Processing the identity shift and agency that comes with rare mutation status: from isolation to making new friends and finding meaning as an advocate

  • Reframing medical anxiety: how regular imaging, informed conversations, and community lessen the burden of living with ongoing risk

  • The evolving relationship with guilt, responsibility, and legacy after learning she passed her mutation on to two of her three children

  • Claiming the power of knowledge—and the importance of finding your people

Highlights & Takeaways

  • “It finally kind of put some validity to this… thought that I was growing melanoma for no reason.”

  • Intergenerational silence around illness can be shifted—with honesty, consent, and honoring each child’s readiness to know.

  • Agency in rare mutations includes not just self-care, but reaching out to others—family, friends, and online communities—for knowledge, relief, and the possibility of healing old wounds.

  • Surveillance isn’t just clinical; it can be emotionally stabilizing, creating peace in uncertain bodies and family systems.

  • There can be empowerment, relief, and even beauty in hunting down the “typo” in the family tree—and meeting kin who share it.

  • Community, data, and emotional support aren’t separate—a rare mutation journey is richer with all three.

Content Note
This episode includes discussion of parental illness and death, intergenerational trauma, genetic guilt, and medical anxiety.

Resources Mentioned

Connect

If this episode resonated, please follow, rate, and share. Find Sara on IG  @FaceTheRiskTogether and get free tools + 1:1/group offerings via the link in bio. You’re not alone—we can walk this line together.